184 results on '"Bieńkowski, Michał"'
Search Results
2. Elevated expression of complement factor I in lung cancer cells associates with shorter survival–Potentially via non-canonical mechanism
3. Evaluation of CSF 8-iso-prostaglandin F2α and erythrocyte anisocytosis as prognostic biomarkers for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
4. Loss of Y in regulatory T lymphocytes in the tumor micro-environment of primary colorectal cancers and liver metastases
5. Real-world treatment outcomes in patients with HR+ HER2- advanced breast cancer treated with CDK4/6 inhibitors and endocrine therapy.
6. Tumor Predisposing Post-Zygotic Chromosomal Alterations in Bladder Cancer—Insights from Histologically Normal Urothelium
7. Prognostic Biomarkers for Delayed Cerebral Ischemia Post-Aneurysmal Subarachnoid Hemorrhage: Evaluating CSF 8-iso-Prostaglandin F2α and Erythrocyte Anisocytosis
8. Pathway-level mutation analysis in primary high-grade serous ovarian cancer and matched brain metastases
9. Bacterial cellulose as a promising material for pulmonary valve prostheses: In vivo study in a sheep model
10. Combination of modified FOLFIRINOX with stereotactic body radiotherapy as an induction therapy for locally advanced pancreatic adenocarcinoma – a prospective single-arm study
11. Effectiveness and safety of immunotherapy in NSCLC patients with ECOG PS score ≥2 – Systematic review and meta-analysis
12. Who Is a Pathologist According to Oncology Patients and Internet Users? A Survey Study
13. Plasma amino acids indicate glioblastoma with ATRX loss
14. Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study
15. Radiotherapy-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with laryngeal cancer indicate poor prognosis
16. Heterogeneity in precision oncology
17. 125 Elevated expression of complement factor I in lung cancer cells associates with shorter survival – Potentially via non-canonical mechanism
18. MAML2 rearrangement as a useful diagnostic marker discriminating between Warthin tumour and Warthin-like mucoepidermoid carcinoma
19. Primarily resectable pancreatic adenocarcinoma – to operate or to refer the patient to an oncologist?
20. Prostate Cancer and Its Mimics—A Pictorial Review
21. Data from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
22. Supplementary Figure S1-S10 from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
23. Supplementary Table 1 from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
24. Supplementary Material and Methods from Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
25. Urinary F2-Isoprostane Concentration as a Poor Prognostic Factor After Subarachnoid Hemorrhage.
26. Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
27. Abstract P2-23-06: Estrogen receptor-negative progesterone receptor-positive breast cancer is a molecularly distinct group characterized by the down-regulation of genes controlled by ESR1 and SUZ12
28. Current and future applications of liquid biopsy in non-small-cell lung cancer—a narrative review
29. Molecular aspects of brain metastases in breast cancer
30. Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer
31. Glucose-6-phosphate dehydrogenase and 8-iso-prostaglandin F2α as potential predictors of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
32. Glucose-6-phosphate dehydrogenase and 8-iso-prostaglandin F2α as potential predictors of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
33. Metastasis to the ureter as the first manifestation of occult pulmonary adenocarcinoma. Case report and review of the literature
34. Additional file 3 of Size matters: the impact of nucleus size on results from spatial transcriptomics
35. Additional file 1 of Size matters: the impact of nucleus size on results from spatial transcriptomics
36. Additional file 4 of Size matters: the impact of nucleus size on results from spatial transcriptomics
37. Additional file 2 of Size matters: the impact of nucleus size on results from spatial transcriptomics
38. Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer
39. Complex EGFR mutations in non-small cell lung cancer: a distinct entity?
40. miRNA signatures of prognostic significance in single hormone receptor-positive breast cancer.
41. Impact of Activation of EGFL7 within Microenvironment of High Grade Ovarian Serous Carcinoma on Infiltration of CD4+ and CD8+ Lymphocytes
42. Comprehensive cancer-oriented biobanking resource of human samples for studies of post-zygotic genetic variation involved in cancer predisposition
43. PARP inhibitors for metastatic castration-resistant prostate cancer: Biological rationale and current evidence
44. Diagnostically misleading aberrant terminal deoxynucleotidyl transferase expression in germ cell tumors
45. Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer
46. PARP inhibitors beyond BRCA-mutated cancers: precision medicine at the crossroads
47. Combined Assessment of Immune Checkpoint Regulator VISTA on Tumor-Associated Immune Cells and Platelet-to-Lymphocyte Ratio Identifies Advanced Germ Cell Tumors with Higher Risk of Unfavorable Outcomes
48. Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies
49. The Role of Urine F2-isoprostane Concentration in Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Haemorrhage—A Poor Prognostic Factor
50. Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.